Accendra Health (ACH)
NYSE:ACH
ACH Stock Chart & Stats
$2.57
--
Market closed
$2.57
--
Day’s Range― - ―
52-Week Range$1.84 - $9.55
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.12M
Market Cap
$214.79M
Enterprise Value$2.19B
Total Cash (Recent Filing)$281.99M
Total Debt (Recent Filing)$2.23B
Price to Earnings (P/E)―
Beta1.06
Next Earnings
May 01, 2026EPS Estimate
-0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.21
Shares Outstanding76,436,810
10 Day Avg. Volume949,424
30 Day Avg. Volume1,122,390
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.47
Price to Sales (P/S)0.08
P/FCF Ratio-0.74
Enterprise Value/Market Cap10.18
Enterprise Value/Revenue0.46
Enterprise Value/Gross Profit1.49
Enterprise Value/Ebitda9.30
Forecast
1Y Price Target
$2.83Price Target Upside10.25% Upside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)0.6
Revenue Forecast (FY)$2.59B
Bulls Say, Bears Say
Bulls Say
Divestiture-driven DeleveragingThe strategic divestiture converted non-core assets into $342M of proceeds used immediately to reduce leverage and settle receivable securitization. This materially improves balance-sheet flexibility, narrows focus to core home-based care, and supports sustainable margin improvement and targeted investments.
Improving Cash Generation And Clear FCF TargetContinuing-operations cash generation rebounded in 2025 and management set a durable free-cash-flow target for 2026. Reliable cash generation reduces refinancing urgency, funds necessary patient CapEx and technology investments, and underpins deleveraging and longer-term operational stability.
Recurring Revenue Growth In Sleep CategoryDouble-digit growth in the sleep supplies category reflects successful product strategy and recurring-revenue capture, strengthening a predictable revenue base. Durable category expansion supports better gross margin realization and offsets volatility in other lines, enhancing revenue resilience over the medium term.
Bears Say
Large Payer Contract LossA $300M structural revenue reduction materially erodes scale and predictable cash flows, increasing per-unit cost pressure and weakening margin economics. Replacement is uncertain and slow, meaning sustained top-line shortfall will pressure adjusted EBITDA, leverage targets and require durable cost or pricing responses.
Negative Equity And High LeverageNegative shareholders’ equity signals deep balance-sheet stress and constrains financial flexibility. Elevated debt levels increase refinancing and covenant risk, limit strategic optionality, and raise the probability of dilutive or costly financing actions, which can impair long-term investment and recovery execution.
Cash-flow DeteriorationThe swing to cash burn undermines liquidity and heightens reliance on asset sales or debt to fund operations and patient CapEx. Even with targets, recent negative OCF and FCF increase execution risk for deleveraging plans and make sustaining growth or funding tech initiatives more challenging in the near term.
Accendra Health News
ACH FAQ
What was Accendra Health’s price range in the past 12 months?
Accendra Health lowest stock price was $1.84 and its highest was $9.55 in the past 12 months.
What is Accendra Health’s market cap?
Accendra Health’s market cap is $214.79M.
When is Accendra Health’s upcoming earnings report date?
Accendra Health’s upcoming earnings report date is May 01, 2026 which is in 17 days.
How were Accendra Health’s earnings last quarter?
Accendra Health released its earnings results on Feb 19, 2026. The company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.221 by -$0.011.
Is Accendra Health overvalued?
According to Wall Street analysts Accendra Health’s price is currently Undervalued.
Does Accendra Health pay dividends?
Accendra Health does not currently pay dividends.
What is Accendra Health’s EPS estimate?
Accendra Health’s EPS estimate is -0.1.
How many shares outstanding does Accendra Health have?
Accendra Health has 76,436,810 shares outstanding.
What happened to Accendra Health’s price movement after its last earnings report?
Accendra Health reported an EPS of $0.21 in its last earnings report, missing expectations of $0.221. Following the earnings report the stock price went up 5.242%.
Which hedge fund is a major shareholder of Accendra Health?
Currently, no hedge funds are holding shares in ACH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Accendra Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$2.83 (10.25% Upside)
$2.83 (10.25% Upside)
Blogger Sentiment
Bullish
ACH Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 281.2K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.19%
12-Months-Change
Fundamentals
Return on Equity
733.13%
Trailing 12-Months
Asset Growth
-47.34%
Trailing 12-Months
Company Description
Accendra Health
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.
ACH Company Deck
ACH Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced picture: structurally positive strategic actions and improving cash generation following the divestiture (completed sale proceeds, strong continuing-operations cash flow, debt reduction, a clear deleveraging target and targeted technology investments). However, material near-term challenges remain — most notably the large commercial payer contract loss (~$300M headwind in 2026), margin pressure from inflationary product costs and one-time separation and stranded costs — which depress near-term revenue and adjusted EBITDA guidance. Management outlined clear remediation actions (cost reduction, technology, preferred agreements and capital structure optimization) and expects improvements over 2026 and into 2027, resulting in a neutral overall outlook in the near term while leaving upside potential if replacement volume and cost initiatives succeed.View all ACH earnings summariesACH Stock 12 Month Forecast
Average Price Target
$2.83
▲(10.25% Upside)